Oasis Advisors’s Idexx Laboratories IDXX Stock Holding History

Oasis Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-490	Closed	-$275K	–	130
2026 Q1	$275K	Buy	+490	New	+$314K	0.05%	177

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Oasis Advisors's IDXX Position: Q2 2026 in Review

Oasis Advisors sold out of Idexx Laboratories (IDXX) in Q2 2026, closing a stake of 490 shares — an estimated $275K sold.

Oasis Advisors first reported a position in IDXX in Q1 2026 and held it in 1 quarter. The position peaked at $275K in Q1 2026. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Oasis Advisors reported no remaining Idexx Laboratories position as of Q2 2026 after selling out during the quarter.
Oasis Advisors sold 490 Idexx Laboratories shares in Q2 2026, an estimated $275K.
Oasis Advisors first reported a position in Idexx Laboratories in Q1 2026 and held it in 1 quarter.
Oasis Advisors's Idexx Laboratories position peaked at $275K in Q1 2026.
1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Oasis Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.